Openreuma Consensus on the role of nursing in the care of patients with rheumatoid arthritis and diffuse interstitial lung disease
DOI:
https://doi.org/10.17533/udea.iee.v40n3e17Keywords:
lung diseases, interstitial, arthritis, rheumatoid, consensus, nursing, safety, efficacyAbstract
Objective. To develop practical recommendations, based on the best available evidence and experience, on the nursing management of patients with rheumatoid arthritis (RA) and interstitial lung disease (ILD).
Methods. The usual consensus methodology was used, with a nominal group, systematic reviews (SRs), and Delphi survey. The expert panel, consisting of rheumatology nurses, rheumatologists, a psychologist, a physiotherapist, and a patient, defined the scope, the users, the topics on which to explore the evidence and on which to issue recommendations.
Results. Three PICO questions evaluated the efficacy and safety of pulmonary rehabilitation and non-pharmacological measures for the treatment of chronic cough and gastroesophageal reflux by means of SR of the literature. With the results of the reviews, 15 recommendations were established for which the degree of agreement was obtained with a Delphi survey. Three recommendations were rejected in the second round. The 12 recommendations were in patient assessment (n=4); patient education (n=4); and risk management (n=4). Only one recommendation was based on available evidence, while the remaining were based on expert opinion. The degree of agreement ranged from 77% to 100%.
Conclusion. This document presents a series of recommendations with the aim of improving the prognosis and quality of life of patients with RA-ILD. Nursing knowledge and implementation of these recommendations can improve the follow-up and prognosis of patients with RA who present with ILD.
Downloads
References
1. Sparks JA, Jin Y, Cho SK, Vine S, Desai R, Doyle TJ, et al. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatol (Oxford). 2021; 60(8):3689-98.
2. Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V. The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease. Arthritis Rheumatol. 2018; 70(10):1544-54.
3. England BR, Hershberger D. Management issues in rheumatoid arthritis-associated interstitial lung disease. Curr. Opin. Rheumatol. 2020; 32(3):255-63.
4. Barbera T, Davila L, Patel NM. Management and support of patients with fibrosing interstitial lung diseases. Nurse Pract. 2021; 46(7):39-44.
5. Lindell KO. Nonpharmacological therapies for interstitial lung disease. Curr. Pulmonol. Rep. 2018; 7(4):126-32.
6. SER-SEPAR. Recomendaciones SER-SEPAR sobre el manejo de la Enfermedad Pulmonar Intersticial Difusa asociada a la Artritis Reumatoide [Internet]; 2022 [cited 27 Sept 2022]. Available from: https://www.ser.es/ recomendaciones-ser-separ-sobre-diagnostico-y-tratamiento-de-la-enfermedad-pulmonar-intersticial-difusa-epid- asociada-a-la-artritis-reumatoide-ar/
7. Grewal JS, Ryerson CJ. A closer look at the multidisciplinary interstitial lung disease clinic: Who, what and how. Respirology. 2021; 26(1):12-3.
8. (NICE) NIoHaCE. Idiopathic pulmonary fibrosis in adults: diagnosis and management [Internet]. 2017 [cited 27 Sept 2022]. Available from: https://www.nice.org.uk/guidance/cg163.
9. Bech B, Primdahl J, van Tubergen A, Voshaar M, Zangi HA, Barbosa L, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann. Rheum. Dis. 2020; 79(1):61-8.
10. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;3 58:j4008.
11. Higgins J SJ, Page M, Elbers R, Sterne J. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor. Cochrane Handbook for Systematic Reviews of Interventions version 6.3; 2022.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin. Trials. 1996; 17(1):1-12.
13. Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations [Internet]. 2013 (cited 27 Sept 2022). Available from: https://gdt.gradepro.org/app/handbook/ handbook.html
14. An J, Nyarko E, Hamad MA. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin. Rheumatol. 2019; 38(10):2717-26.
15. Radner H, Smolen JS, Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2010; 69(3):536-41.
16. Loza E, Lajas C, Andreu JL, Balsa A, Gonzalez-Alvaro I, Illera O, et al. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int. 2015; 35(3):445-58.
17. Castaneda S, Gonzalez C, Villaverde V, Lajas Petisco C, Castro MC, Jirout F, et al. Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project. Reumatol. Clin. (Engl Ed). 2022; 18(2):114-23.
18. Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann. Rheum. Dis. 2015; 74(9):1725-33.
19. Russell AM, Olive S, Lines S, Murphy A, Hocking J, Newell K, et al. Contemporary challenges for specialist nursing in interstitial lung disease. Breathe (Sheff). 2018; 14(1):36-41.
20. Baker KM, DeSanto-Madeya S, Banzett RB. Routine dyspnea assessment and documentation: Nurses’ experience yields wide acceptance. BMC Nurs. 2017; 16:3.
21. Perez T, Burgel PR, Paillasseur JL, Caillaud D, Deslee G, Chanez P, et al. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2015 ;10:1663-72.
22. Ritschl V, Stamm TA, Aletaha D, Bijlsma JWJ, Bohm P, Dragoi RG, et al. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Ann. Rheum. Dis. 2021; 80(6):707-13.
23. Velasco-Gonzalez V, Loya-Perez L, Navarro-Garcia E, Sainz-Gil M. Reporting of suspected adverse drug reactions by nursing in Spain. An observational-descriptive retrospective study. Enferm. Clin (Engl. Ed). 2021; S1130- 8621(20):30534-9.
24. Salehi T, Seyedfatemi N, Mirzaee MS, Maleki M, Mardani A. Nurses’ Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review. Biomed Res. Int. 2021; 6630404.
25. Dai Y, Wang W, Yu Y, Hu S. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Clin. Rheumatol. 2021; 40(4):1211-20.
26. Salaffi F, Carotti M, Di Carlo M, Tardella M, Giovagnoni A. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities. Medicine (Baltimore). 2019 ;98(38):e17088.
27. Zhang Y, Li H, Wu N, Dong X, Zheng Y. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin. Rheumatol. 2017; 36(4):817-23.
28. Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology (Oxford). 2017; 56(3):344-50.
29. Rice VH, Heath L, Livingstone-Banks J, Hartmann-Boyce J. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2017;12(12):CD001188.
30. Casanova C, Baudet JS, del Valle Velasco M, Martin JM, Aguirre-Jaime A, de Torres JP, et al. Increased gastro- oesophageal reflux disease in patients with severe COPD. Eur. Respir J. 2004; 23(6):841-5.
31. Meyer KC. Gastroesophageal reflux and lung disease. Expert Rev. Respir. Med. 2015; 9(4):383-5.
32. Albarqouni L, Moynihan R, Clark J, Scott AM, Duggan A, Del Mar C. Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review. BMC Fam. Pract. 2021; 22(1):24.
33. Capparelli I, Fernandez M, Saadia Otero M, Steimberg J, Brassesco M, Campobasso A, et al. Translation to Spanish and Validation of the Specific Saint George’s Questionnaire for Idiopathic Pulmonary Fibrosis. Arch. Bronconeumol. (Engl Ed). 2018; 54(2):68-73.
34. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King’s Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012 ;67(9):804-10.
35. Fernández M, Rodríguez-Barreto O, Buendía-Roldán I, Aberti M, Caro F, Ipuche F. Prevalence of anxiety and depression and their relationship with clinical characteristics in patients with interstitial lung disease. J. Gerontol. Res. 2019; 8(4):505.
36. Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, et al. Patient-reported outcomes and patient- reported outcome measures in interstitial lung disease: where to go from here? Eur.Respir. Rev. 2021; 30(160).
37. Guler SA, Ryerson CJ. Frailty in patients with interstitial lung disease. Curr. Opin. Pulm. Med. 2020; 26(5):449- 56.
38. Pons Raventos M, Rebollo Rubio A, Jiménez Ternero J. Fragilidad: ¿Cómo podemos detectarla? Enferm. Nefrol. 2016; 19(2):170-3.
39. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 2001; 56(3):M146-56.
40. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. CMAJ. 1994; 150(4):489-95.
41. Ministerio de Sanidad. Documento de consenso sobre prevención de fragilidad y caídas en la persona mayor 2014 [Internet]. Available from: https://www.sanidad.gob.es/ca/profesionales/saludPublica/prevPromocion/Estrategia/ docs/Fragilidad/FragilidadyCaidas_personamayor.pdf.
42. Romero Ortuno R. [The Frailty Instrument for primary care of the Survey of Health, Ageing and Retirement in Europe (SHARE-FI): results of the Spanish sample]. Rev. Esp. Geriatr. Gerontol. 2011; 46(5):243-9.
43. Garcia-Garcia FJ, Carcaillon L, Fernandez-Tresguerres J, Alfaro A, Larrion JL, Castillo C, et al. A new operational definition of frailty: the Frailty Trait Scale. J. Am. Med. Dir. Assoc. 2014; 15(5):371 e7-e13.
44. de la Torre Aboki J. [Contribution of nurse-led clinics in the management of the patient with rheumatoid arthritis]. Reumatol. Clin. 2011; 6S3:S16-9.
45. Gomez Reino J, Loza E, Andreu JL, Balsa A, Batlle E, Canete JD, et al. [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients]. Reumatol. Clin. 2011; 7(5):284- 98.
Published
Versions
- 2023-09-20 (2)
- 2022-11-12 (1)
How to Cite
Issue
Section
License
Copyright (c) 2022 Investigación y Educación en Enfermería
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Derechos de propiedad / Direitos de Propriedade
English: If the article is accepted for publication, all copyright will be of exclusive property of Investigación y Educación en Enfermería. The text and the graphics included in the publication are exclusive responsibility of the authors and not necessarily reflect the thought of the Editorial Committee.
Español: Si el artículo es aprobado para publicación, todos los derechos son de propiedad de Investigación y Educación en Enfermería. El texto y las gráficas incluidas en la publicación son de exclusiva responsabilidad de los autores y no necesariamente refleja el pensamiento del Comité Editorial.
Português: Se o artigo for aceito para publicação, todos os direitos autorais serão de propriedade exclusiva de Investigación y Educación en Enfermería. O texto e os gráficos incluídos na publicação são de responsabilidade exclusiva dos autores e não refletem necessariamente o pensamento do Comitê Editorial.
